跳到主要导航
跳到搜索
跳到主要内容
北京理工大学 首页
English
中文
首页
师资队伍
研究单位
科研成果
奖项
按专业知识、名称或附属进行搜索
查看 Scopus 资料
印 悦
医学技术学院
h-index
1183
引用
16
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
2018
2024
每年的科研成果
概览
指纹图谱
合作网络
科研成果
(33)
指纹图谱
深入其中 Yue Yin 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Alpha2 Interferon
16%
Antibody-Dependent Cell-Mediated Cytotoxicity
6%
Antitumor Activity
16%
Bile Acid Conjugate
16%
Biological Product
16%
Breast Tumor
16%
Cancer Vaccine
16%
Catechol
8%
Chemoattractant
10%
Dextran
12%
Disulfide Bond
10%
DNA
16%
DNA Vaccine
16%
Gamma Interferon
16%
Granulocyte Macrophage Colony Stimulating Factor
8%
Graphene Oxide
33%
Human Interferon
16%
Immunogenicity
5%
Immunosuppressive Agent
5%
Immunotherapy
21%
Intramuscular Injection
12%
Lung Carcinoma
16%
Malignant Neoplasm
30%
Mesoporous Silica
8%
Metal Ion
16%
Methacrylate
16%
Methotrexate
16%
Nanomaterial
36%
Neoplasm
15%
Nucleocapsid Protein
5%
Onion
16%
Ovary Tumor
6%
P-Selectin
16%
Phenylalanine
16%
Polyethyleneimine
16%
Polyinosinic Polycytidylic Acid
6%
Resiquimod
33%
Small Interfering RNA
16%
Stimulant
6%
Subcutaneous Injection
20%
Toll Like Receptor 3
8%
Tumor Microenvironment
6%
Material Science
Bioactive Material
16%
Biomaterial
16%
Biomedical Materials
16%
Cell Death
10%
Copolymer
33%
DNA
16%
Electrospinning
16%
Graphene Oxide
33%
Hydrogel
50%
Lymphocyte
16%
Medical Device
6%
Mesoporous Silica
8%
Mitochondrion
16%
Nanocrystalline Material
28%
Nanoparticle
28%
Nucleic Acid
16%
Photosensitizer
7%
Polyelectrolyte
9%
Polyethylene Glycol
29%
Polymer Network
16%
Solid Lipid Nanoparticle
16%
Stem Cell
16%
T-Cells
23%
Tumor
100%
Medicine and Dentistry
Alternative Complement Pathway C3 C5 Convertase
5%
Amino Acid Transport
5%
Carbon Metabolism
7%
Dextran
12%
Diet Therapy
5%
DNA
16%
Effusion
5%
Gene Delivery
16%
Hybrid Gene
16%
Isotopes of Calcium
12%
Lung Carcinoma
16%
Macrogol
12%
Medical Device
11%
Medicine
16%
Methotrexate
16%
Monotherapy
16%
Nanomaterial
5%
Nuclear Factor
5%
Nucleotide Metabolism
16%
Nutrient Sensing
16%
Ovarian Tumor
11%
Paclitaxel
5%
Phenylalanine
10%
Polypharmacy
5%
Small Interfering RNA
16%
